Загрузка...
Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects
Tofacitinib is an oral disease-modifying anti-rheumatic drug to selectively inhibit Janus kinases. Tofacitinib is a representative small molecule inhibitor that is used to treat many diseases including rheumatoid arthritis and various autoimmune conditions. Unlike biological agents, tofacitinib has...
Сохранить в:
| Опубликовано в: : | Transl Clin Pharmacol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Society for Clinical Pharmacology and Therapeutics
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7533161/ https://ncbi.nlm.nih.gov/pubmed/33062629 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12793/tcp.2020.28.e13 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|